Spyre Therapeutics (SYRE) Depreciation & Amortization (CF) (2015 - 2023)
Spyre Therapeutics posted quarterly Depreciation & Amortization (CF) of $360000.0 for Q2 2023, down 4.76% year-on-year from $378000.0 in Q2 2022, and down 6.25% on a QoQ basis from $384000.0 in Q1 2023.
Spyre Therapeutics (SYRE) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $360000.0 in Q2 2023.
- For the quarter ending Q2 2023, Depreciation & Amortization (CF) fell 4.76% year-over-year to $360000.0; the trailing twelve-month figure through Mar 2024 stood at $360000.0 (down 76.74% YoY), and the FY2023 full-year result was $744000.0, down 52.52% from the prior year.
- Depreciation & Amortization (CF) for Q2 2023 stood at $360000.0, down from $384000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $412000.0 in Q3 2021 and bottomed at $100000.0 in Q1 2019.
- The 5-year median for Depreciation & Amortization (CF) is $364500.0 (2020), against an average of $294500.0.
- The widest annual swing landed in 2020, when Depreciation & Amortization (CF) soared 248.11%; it then slipped 6.33% in 2022.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $106000.0 in 2019, then jumped by 248.11% to $369000.0 in 2020, then advanced by 11.38% to $411000.0 in 2021, then retreated by 6.33% to $385000.0 in 2022, then retreated by 6.49% to $360000.0 in 2023.
- The last three Depreciation & Amortization (CF) figures came in at $360000.0 (Q2 2023), $384000.0 (Q1 2023), and $385000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Spyre Therapeutics | 5.55 Bn | 5.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 360,000.00 |
| Jun 30, 2023 | 360,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Dec 31, 2022 | 385,000.00 |
| Dec 31, 2022 | 385,000.00 |
| Sep 30, 2022 | 401,000.00 |
| Sep 30, 2022 | 401,000.00 |
| Jun 30, 2022 | 378,000.00 |
| Jun 30, 2022 | 378,000.00 |
| Mar 31, 2022 | 403,000.00 |
| Mar 31, 2022 | 403,000.00 |
| Dec 31, 2021 | 411,000.00 |
| Dec 31, 2021 | 411,000.00 |
| Sep 30, 2021 | 412,000.00 |
| Sep 30, 2021 | 412,000.00 |
| Jun 30, 2021 | 398,000.00 |
| Jun 30, 2021 | 398,000.00 |
| Mar 31, 2021 | 355,000.00 |
| Mar 31, 2021 | 355,000.00 |
| Dec 31, 2020 | 369,000.00 |
| Dec 31, 2020 | 369,000.00 |
| Sep 30, 2020 | 251,000.00 |
| Sep 30, 2020 | 251,000.00 |
| Jun 30, 2020 | 222,000.00 |
| Jun 30, 2020 | 222,000.00 |
| Mar 31, 2020 | 154,000.00 |
| Mar 31, 2020 | 154,000.00 |
| Dec 31, 2019 | 106,000.00 |
| Dec 31, 2019 | 106,000.00 |
| Sep 30, 2019 | 105,000.00 |
| Sep 30, 2019 | 105,000.00 |
| Jun 30, 2019 | 107,000.00 |
| Jun 30, 2019 | 107,000.00 |
| Mar 31, 2019 | 100,000.00 |
| Mar 31, 2019 | 100,000.00 |
| Dec 31, 2018 | 79,000.00 |
| Dec 31, 2018 | 79,000.00 |
| Sep 30, 2018 | 76,000.00 |
| Sep 30, 2018 | 76,000.00 |
| Jun 30, 2018 | 75,000.00 |
| Jun 30, 2018 | 75,000.00 |
| Mar 31, 2018 | 70,000.00 |
| Mar 31, 2018 | 70,000.00 |
| Dec 31, 2017 | 66,000.00 |
| Dec 31, 2017 | 66,000.00 |
| Sep 30, 2017 | 69,000.00 |
| Sep 30, 2017 | 69,000.00 |
| Jun 30, 2017 | 62,000.00 |
| Jun 30, 2017 | 62,000.00 |
| Mar 31, 2017 | 52,000.00 |
| Mar 31, 2017 | 52,000.00 |
| Dec 31, 2016 | 36,000.00 |
| Dec 31, 2016 | 36,000.00 |
| Sep 30, 2016 | 34,000.00 |
| Sep 30, 2016 | 34,000.00 |
| Jun 30, 2016 | 33,000.00 |
| Jun 30, 2016 | 33,000.00 |
| Mar 31, 2016 | 29,000.00 |
| Mar 31, 2016 | 29,000.00 |
| Dec 31, 2015 | 29,000.00 |
| Dec 31, 2015 | 29,000.00 |
| Sep 30, 2015 | 25,000.00 |
| Sep 30, 2015 | 25,000.00 |
| Jun 30, 2015 | 18,000.00 |
| Jun 30, 2015 | 18,000.00 |
| Mar 31, 2015 | 17,000.00 |
| Mar 31, 2015 | 17,000.00 |